What does clinical trials — gain loss on sale of business mean?

The net financial gain or loss resulting from selling off parts of the clinical trials business unit.

Discontinued — last reported Q3 '15

Business Segments · Gain Loss On Sale Of Business

Clinical Trials — Gain Loss On Sale Of Business

Analysis

StatementSegment

CategoryCapital Allocation

SignalHigher is better

VolatilityVolatile

First reportedQ3 2015

Last reportedQ3 2015Feb 22, 2017

Rolls up toGain (loss) on disposal of assets

How to read this metric

A gain indicates successful divestiture of non-core assets at a premium, while a loss may suggest impairment or a strategic exit at a discount. Frequent or large fluctuations indicate active portfolio restructuring within the clinical trials division.

Detailed definition

This metric represents the net profit or loss recognized from the divestiture of assets, product lines, or business unit...

Peer comparison

Peers in the diagnostic and contract research organization (CRO) space often report similar gains or losses under 'Other Income' or 'Discontinued Operations' when streamlining their service portfolios.

Metric ID: dgx_segment_clinical_trials_gain_loss_on_sale_of_business

Similar Metrics at Other Companies

Tyson FoodsTSN View metric

STERISSTE View metric

Brown & BrownBRO View metric

AWK

American Water WorksAWK View metric

DuPont de Nemours, Inc.DD View metric

Frequently Asked Questions

What does clinical trials — gain loss on sale of business mean?: The net financial gain or loss resulting from selling off parts of the clinical trials business unit.